ArticleEndocrinology, diabetes & metabolism case reports2025
The paradox of hypothyroidism: elevated cardiac biomarkers without coronary artery disease.
Article in Endocrinology, diabetes & metabolism case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Summary: This case report describes a 55-year-old male with hypothyroidism who presented with chest pain, elevated cardiac biomarkers (creatine kinase-MB (CK-MB) and troponin T), and abnormal electrocardiogram (ECG), findings suggestive of acute coronary syndrome (ACS). Despite clinical suspicion of myocardial ischemia, coronary angiography revealed no significant coronary artery disease. Profound hypothyroidism, confirmed by markedly elevated thyroid-stimulating hormone (TSH) and anti-thyroid peroxidase antibodies, was identified as the underlying cause of the cardiac biomarker abnormalities. Treatment with thyroxine resulted in clinical improvement and normalization of cardiac markers. This case underscores the importance of considering hypothyroidism in the differential diagnosis of elevated cardiac enzymes and ischemic symptoms in the absence of coronary artery disease. Learning points: Hypothyroidism should be considered in patients presenting with ischemic symptoms and elevated cardiac biomarkers, in the absence of coronary artery disease. Elevated CK-MB and troponin in hypothyroidism may result from non-cardiac mechanisms, posing significant diagnostic challenges. Thyroid function tests should be routinely included in the diagnostic evaluation of patients with atypical presentations of myocardial injury. Timely diagnosis and management of hypothyroidism can help avoid misdiagnosis and unnecessary invasive interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.